Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) FCF Payout Ratio: 2021-2025

Historic FCF Payout Ratio for Ani Pharmaceuticals (ANIP) over the last 4 years, with Sep 2025 value amounting to 0.01.

  • Ani Pharmaceuticals' FCF Payout Ratio fell 82.89% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 52.58%. This contributed to the annual value of 0.03 for FY2024, which is 130.41% up from last year.
  • As of Q3 2025, Ani Pharmaceuticals' FCF Payout Ratio stood at 0.01, which was up 59.90% from 0.01 recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' FCF Payout Ratio ranged from a high of 0.35 in Q3 2022 and a low of -0.05 during Q4 2022.
  • For the 3-year period, Ani Pharmaceuticals' FCF Payout Ratio averaged around 0.02, with its median value being 0.02 (2023).
  • As far as peak fluctuations go, Ani Pharmaceuticals' FCF Payout Ratio crashed by 256.38% in 2022, and later soared by 297.15% in 2024.
  • Ani Pharmaceuticals' FCF Payout Ratio (Quarterly) stood at -0.02 in 2021, then tumbled by 256.38% to -0.05 in 2022, then spiked by 117.71% to 0.01 in 2023, then skyrocketed by 215.32% to 0.03 in 2024, then tumbled by 82.89% to 0.01 in 2025.
  • Its FCF Payout Ratio stands at 0.01 for Q3 2025, versus 0.01 for Q2 2025 and 0.01 for Q1 2025.